30-Second Takeaway
- Biobank-scale CNV, GWAS, and QTL resources now link specific structural and noncoding variants to proteins and complex disease risk.
- Patient-derived RNA-seq and prenatal exome sequencing modestly increase diagnostic yield, particularly for splice and intronic variants.
- Rare heterozygous variants in classically recessive genes can drive adult-onset disease, reshaping risk counseling and surveillance.
- Polygenic and rare-variant architectures converge at many loci, clarifying which pathways drive anthropometric and endocrine traits.
- Functional genomics and caQTL atlases help prioritize causal noncoding variants and effector genes from hematologic and cardiometabolic GWAS.
Week ending February 7, 2026
Integrating structural, regulatory, and rare variation into risk prediction and diagnostics across diverse genetic disorders
Biobank-scale CNV PheWAS connects dosage to proteins and complex disease
Analysis of 470,727 UK Biobank genomes linked CNVs to 2,941 plasma proteins, 13,336 binary phenotypes, and 1,911 quantitative traits. Deletions and duplications usually decreased and increased nearby protein levels, respectively, confirming CNV-driven cis-pQTL dosage effects. The study highlighted clinically relevant CNVs, including a rare ZNF451 deletion increasing leukocyte telomere length and a SLC2A9 enhancer deletion lowering gout risk. Combining CNVs with coding SNVs and indels improved gene–disease association detection and nominated pQTLs, such as TMPRSS5, as candidate biomarkers.
Multi-ancestry GWAS maps shared genetic architecture of thyroid diseases
Meta-analysis of ~2.9 million genomes across 19 biobanks identified 313 known and 570 novel loci for thyroid cancer and four benign thyroid diseases. Genetic correlations between thyroid cancer, benign nodular goiter, and autoimmune thyroid diseases ranged from 0.16 to 0.97, indicating shared predisposition. Telomere maintenance genes contributed to benign and malignant nodular disease, whereas cell cycle, DNA repair, and damage response pathways were specific to thyroid cancer. Polygenic risk scores associated with structural recurrence, tumor size, multifocality, lymph node metastases, and extranodal extension, supporting genetically informed risk stratification.
Fibroblast RNA-seq adds targeted diagnostic yield in dystonia
In 167 predominantly early-onset, non-focal dystonia patients, fibroblast RNA-seq interrogated expression and splicing defects beyond prior genomic sequencing. More than 80% of dystonia genes were expressed, enabling focused detection of significant RNA aberrations in disease-associated genes. RNA-seq effectively validated loss-of-function variants, with disease-relevant underexpression observed in two-thirds of such alleles tested. Among 131 unsolved cases, RNA-seq plus reanalysis provided a 6.9% diagnostic uplift, mainly autosomal recessive combined dystonias from splice-region and deep intronic variants.
References
Numbered in order of appearance. Click any reference to view details.
Additional Reads
Optional additional studies from this edition.